Dr. DeJesus is Medical Director of the Orlando Immunology Center in downtown Orlando, Fla. Dr. DeJesus is also the medical director of the HUG-Me Program's adult clinic at Orlando Regional Medical Center.

Since 1993, Dr. DeJesus has devoted most of his time to caring for HIV- and hepatitis-infected patients. He is also deeply involved in HIV-related research: He is the principal investigator for the Orlando Immunology Center Research Facility, where he oversees several phase 1-4 clinical trials. In this capacity, he has presented study results at major international conferences, including the International AIDS Conference, International AIDS Society Conference, Interscience Conference on Antimicrobial Agents and Chemotherapy, Conference on Retroviruses and Opportunistic Infections and European AIDS Conference.

Dr. DeJesus is a graduate from the University of Puerto Rico, School of Medicine. He completed his Internal Medicine training and Infectious Disease fellowship at the Medical College of Pennsylvania in Philadelphia and is board certified in Internal Medicine and Infectious Diseases. He has been a Fellow of the American College of Physicians since 1996.

Dr. DeJesus has remained highly active in Florida's Hispanic community, in which he has implemented and supported educational, preventive and research programs pertaining to HIV. He also writes a biweekly educational column for a local newspaper. He has participated as a guest speaker for community programs, medical forums and as part of infectious diseases training for the Florida Hospital Residency Program.

Previously, Dr. DeJesus served as a consultant for the Florida Department of Corrections, where he participated in the prototype HIV Prison Unit currently operating in Central Florida.

Disclosures

Edwin DeJesus, M.D., has received grants and research support from Abbott Laboratories, Boehringer Ingelheim (BI), Bristol-Myers Squibb Company (BMS), Gilead Sciences Inc., GlaxoSmithKline, Hoffmann-La Roche Inc., Merck & Co. Inc., Pfizer Inc., Schering-Plough Corporation and Tibotec Therapeutics. He has been a consultant to BI, BMS, Gilead, GSK, Merck, Tibotec and Vertex Pharmaceuticals Inc., and he serves on speakers bureaus for Gilead, GSK, Merck and Tibotec.